Mediwhale Inc.
Tuesday, June 04, 2024
Company Presentation
AI and Digital Health
Company Presentation Theater 3
Mediwhale: Revolutionizing Metabolic Care with AI
At Mediwhale, we transform cardio-metabolic health in primary care. Our personalized AI solutions prioritize accessibility and safety, ensuring better outcomes.
Reti-CVD: Our cutting-edge AI analyzes retinal blood vessels, precisely calculating future cardio-metabolic disease risk. It outperforms standard tests and is comparable to cardiac CT scans in accuracy.
Commercialization: Regulatory approvals in eight territories, including Europe, the UK, Australia, Singapore, and Korea, position Reti-CVD as the novel standard for cardio-metabolic care. As the first code for outpatient cases in the Korean market, Reti-CVD secures reimbursement, driving adoption among primary care doctors.
Global Impact: Healthcare professionals recognize Reti-CVD as the innovative solution for cardio-metabolic care.
Company Website:
http://www.mediwhale.com
Lead Product in Development:
Reti-CVD
- SaMD: Cardiovascular risk assessment SW (3rd grade medical device in Korea)
- Cardiovascular disease risk prediction
Number Of Unlicensed Products (For Which You Are Seeking Partners):
2
Company HQ City
Seoul
Company HQ State
Seoul
Company HQ Country
Korea, Republic of
CEO/Top Company Official
CEO | Kevin Choi
- A young and rapidly growing digital healthcare entrepreneur.
CMO | Tyler Rim
- An accomplished clinical scientist, recognized as one of the “TOP 2% scientists in the world in
2022” by Stanford and Elsevier.
- Holds a dual role as an ophthalmologist and a Ph.D.
- Also possesses an M.B.A. CTO | Alex Nam
- A leading expert in artificial intelligence (AI).
- Notable achievements include contributions to conferences such as NIPS(1), CVPR(3), ICCV(1), and ECCV(1).
CPO | Young Lee
- A seasoned professional with extensive experience in software as a medical device.
- Distinguished as the main author of top medical journals, including The Lancet Digital Health.
COO | Nina Shin
- Demonstrates exceptional skills in operation and management. - Holds an M.B.A. from Harvard University.
Development Phase of Primary Product
NDA Preparation/In Review
Speakers
)